Asset Management One
CRL icon

Asset Management One’s Charles River Laboratories CRL Stock Holding History

Asset Management One’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
1,976
+166
+9% +$29.6K ﹤0.01% 841
2026
Q1 		$312K Sell
1,810
-37
-2% -$6.86K ﹤0.01% 830
2025
Q4 		$375K Buy
1,847
+71
+4% +$12.9K ﹤0.01% 834
2025
Q3 		$278K Buy
1,776
+151
+9% +$24K ﹤0.01% 852
2025
Q2 		$247K Buy
1,625
+135
+9% +$18K ﹤0.01% 861
2025
Q1 		$224K Sell
1,490
-17,428
-92% -$2.92M ﹤0.01% 866
2024
Q4 		$3.52M Buy
18,918
+315
+2% +$60.7K 0.01% 672
2024
Q3 		$3.66M Buy
18,603
+26
+0.1% +$5.4K 0.01% 673
2024
Q2 		$3.84M Sell
18,577
-192
-1% -$43.5K 0.01% 637
2024
Q1 		$5.09M Sell
18,769
-1,043
-5% -$249K 0.02% 590
2023
Q4 		$4.73M Sell
19,812
-761
-4% -$150K 0.02% 606
2023
Q3 		$4.03M Buy
20,573
+1,474
+8% +$303K 0.02% 628
2023
Q2 		$4.02M Sell
19,099
-1,683
-8% -$335K 0.02% 648
2023
Q1 		$4.19M Buy
20,782
+1,278
+7% +$290K 0.02% 626
2022
Q4 		$4.36M Sell
19,504
-448
-2% -$97.8K 0.02% 599
2022
Q3 		$3.93M Sell
19,952
-1,405
-7% -$303K 0.02% 626
2022
Q2 		$4.57M Sell
21,357
-1,205
-5% -$294K 0.02% 610
2022
Q1 		$6.41M Buy
22,562
+206
+0.9% +$63.5K 0.03% 577
2021
Q4 		$8.35M Sell
22,356
-2,545
-10% -$989K 0.03% 530
2021
Q3 		$10.3M Buy
24,901
+953
+4% +$396K 0.04% 464
2021
Q2 		$8.86M Buy
23,948
+21,550
+899% +$7.2M 0.03% 521
2021
Q1 		$695K Sell
2,398
-1,985
-45% -$552K ﹤0.01% 896
2020
Q4 		$1.09M Buy
4,383
+66
+2% +$15.7K ﹤0.01% 841
2020
Q3 		$978K Hold
4,317
– – ﹤0.01% 837
2020
Q2 		$753K Sell
4,317
-3,764
-47% -$601K ﹤0.01% 856
2020
Q1 		$1.02M Buy
8,081
+1,381
+21% +$207K 0.01% 803
2019
Q4 		$1.02M Hold
6,700
– – ﹤0.01% 868
2019
Q3 		$887K Buy
6,700
+800
+14% +$107K ﹤0.01% 882
2019
Q2 		$837K Sell
5,900
-18,826
-76% -$2.55M ﹤0.01% 910
2019
Q1 		$3.59M Buy
+24,726
New +$3.25M 0.02% 678
2016
Q4 		– Sell
-117,480
Closed -$9.79M – 1041
2016
Q3 		$9.79M Sell
117,480
-29,886
-20% -$2.51M 0.15% 156
2016
Q2 		$12.1M Sell
147,366
-4,211
-3% -$347K 0.18% 126
2016
Q1 		$11.5M Hold
151,577
– – 0.17% 139
2015
Q4 		$12.2M Sell
151,577
-1,914
-1% -$138K 0.18% 132
2015
Q3 		$9.75M Hold
153,491
– – 0.15% 163
2015
Q2 		$10.8M Hold
153,491
– – 0.15% 170
2015
Q1 		$12.2M Hold
153,491
– – 0.15% 168
2014
Q4 		$9.77M Hold
153,491
– – 0.13% 203
2014
Q3 		$9.17M Hold
153,491
– – 0.13% 195
2014
Q2 		$8.21M Buy
+153,491
New +$8.42M 0.12% 193

Other funds holding CRL

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Asset Management One's CRL Position: Q2 2026 in Review

Asset Management One increased its Charles River Laboratories (CRL) stake by 9.2% in Q2 2026, buying an estimated $29.6K and bringing the position to 1,976 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Asset Management One first reported a position in CRL in Q2 2014 and has held it in 40 quarters since. The position peaked at $12.2M in Q4 2015. 149 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Asset Management One held 1,976 shares of Charles River Laboratories worth $448K as of Q2 2026.
  • Asset Management One bought 166 Charles River Laboratories shares in Q2 2026, an estimated $29.6K.
  • Charles River Laboratories made up ﹤0.01% of Asset Management One's portfolio in Q2 2026, its #841 holding.
  • Asset Management One first reported a position in Charles River Laboratories in Q2 2014 and has held it in 40 quarters since.
  • Asset Management One's Charles River Laboratories position peaked at $12.2M in Q4 2015.
  • 149 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.